The Maguire family is united in fighting the war on T1D. To participate in TrialNet research, they travel from Sault Ste. Marie, Ontario, to the Hospital for Sick Children at the University of Toronto every 6 months. That's a 7.5-hour drive, often through plenty of snow!

Diagnosed with type 1 diabetes (T1D) at age 11, Jennifer McVean, MD, had not heard of TrialNet until she began working as a pediatric endocrinologist. Now, as part of the pediatric endocrinology team at University of Minnesota, Dr. McVean is a TrialNet advocate heavily involved in spreading the word about screening and studies.

A newly launched prevention study will test the drug hydroxychloroquine (HCQ) to see if it can delay or prevent early stage T1D (stage 1) from progressing to abnormal glucose tolerance (stage 2) and ultimately prevent clinical diagnosis (st